ALK is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains ALK status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].

BCL2 is an inclusion eligibility criterion in 4 clinical trials for Richter syndrome, of which 3 are open and 1 is closed. Of the trials that contain BCL2 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) and 3 are phase 1/phase 2 (2 open) [3].

BCL6 is an inclusion eligibility criterion in 4 clinical trials for Richter syndrome, of which 3 are open and 1 is closed. Of the trials that contain BCL6 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) and 3 are phase 1/phase 2 (2 open) [3].

IRF4 is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains IRF4 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].

MECOM is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains MECOM status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].

MLF1 is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains MLF1 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].

MYC is an inclusion eligibility criterion in 4 clinical trials for Richter syndrome, of which 3 are open and 1 is closed. Of the trials that contain MYC status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) and 3 are phase 1/phase 2 (2 open) [3].

NPM1 is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains NPM1 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].

RPN1 is an inclusion eligibility criterion in 1 clinical trial for Richter syndrome, of which 1 is open and 0 are closed. Of the trial that contains RPN1 status and Richter syndrome as inclusion criteria, 1 is phase 1 (1 open) [3].